dsdsa

huahana

Papa Laʻau Lapaʻau 1392275-56-7 Tenofovir alafenamide fumarate no ka mālama ʻana i ka maʻi Hepatitis B mau loa.

ʻO ka wehewehe pōkole:


  • Maʻemaʻe:≧98%, Keʻokeʻo a i ʻole ka pauka keʻokeʻo
  • palapala hōʻoia:COA, MOA, MSDS, etc
  • Kaha:50Kgs/Mahina
  • Ke ola papa:2 Makahiki
  • Noi:he maʻi hepatitis B nucleotide reverse transcriptase inhibitor no ka mālama ʻana i ka maʻi hepa B
  • Pōmaikaʻi Hui:ʻO ka hui kūʻai hoʻokuʻu aku ʻike me ke kaʻaahi ʻoihana ma ka hale hana
  • Huahana Huahana

    FAQ

    Huahana Huahana

    Huahanainoa ʻO Tenofovir alafenamide fumarate
    Nā huaʻōlelo like N-[(S)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine 1-methylethyl ester (2E)-2 -butenedioate (2: 1);GS 7340-03
    CAS No. 1392275-56-7
    Ka nana aku Keʻokeʻo a aneane keʻokeʻo crystalline pauda
    ʻĀpana Molekala 2(C21H29N6O5P).C4H4O4
    Kaumaha Molekala 1069.02
    Hoʻohana Papa Laʻau Laʻau no ka Noʻonoʻo
    Hoʻopili E like me kāu noi
    Waihona E mālama i loko o nā pahu paʻa a me ka māmā ma kahi anuanu

    ʻIkepili Hui

    √ Ka ʻike piha o ka papa hoʻokele ma ka hale hana a me nā mea ʻenehana akamai;
    √ ʻO ka maikaʻi ka mea i manaʻo nui ʻia, ʻōnaehana QC koʻikoʻi;
    √ 11 makahiki i ʻike i ka lawe ʻana i nā hui kūʻai;
    √ Keʻena hana R&D kūʻokoʻa;
    √ ʻElua mau papa hana GMP lōʻihi i pūlima ʻia;
    √ Nā waiwai waiwai o nā hale hana palaualelo no ka papahana maʻamau;
    √ Kiʻekiʻe Efficiency hui hana me ke ala mau.
    imgsafSDGSHDASFG

  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou